CD4 and renal cell carcinoma: Similarly, across 5 other scRNA-seq data cohorts including NPC, BRCA, AM, CM, and RCC, we consistently observed a robust positive association between apCAFs gene signature scores and CD4+ effector T cells gene signature scores (Supplementary Figures 8A-E).